The abstract is read at the publisher; the summary is JClub's.
Asprosin accelerates vascular aging and endothelial dysfunction in aging mice, and in ApoE−/− mice on HFD it alleviates atherosclerosis when ASP is absent.
- Why it matters: Vascular aging involves endothelial senescence, inflammation, and mitochondrial dysfunction, but whether asprosin drives these processes and through what mechanism is unclear.
- What they did: Gene expression profiling (GSE45540) links FBN1 upregulation to asprosin in human microvascular endothelial cells, and serum asprosin rises with age in mice; in HUVECs, asprosin triggers mtROS, mtDNA leakage, and STING activation, with STING knockdown or mitoTEMPO reducing senescence.
- The result: These data support a mtROS-dependent pathway where asprosin promotes mtDNA leakage and cytosolic STING signaling, and they indicate ASP deficiency or antibody intervention can attenuate vascular aging and endothelial dysfunction in aging mice.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.